Immunotherapeutic potential of N-formylated peptides of ESAT-6 and glutamine synthetase in experimental tuberculosis

International Immunopharmacology

Volumn 18, Issue 2, 2014, Pages 298-303

  Mir, Shabir Ahmad ^a   Sharma, Sadhna ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antituberculosis drugs; Chemotherapy; Early secreted antigenic target 6 and glutamine synthetase; Immunotherapy; N formylated peptides

Indexed keywords

EARLY SECRETORY ANTIGENIC TARGET 6; GLUTAMATE AMMONIA LIGASE; ISONIAZID; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACILLI; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOTHERAPY; INFANT; LUNG; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN; THERAPY EFFECT; TUBERCULOSIS;

ANTITUBERCULOSIS DRUGS; CHEMOTHERAPY; EARLY SECRETED ANTIGENIC TARGET-6 AND GLUTAMINE SYNTHETASE; IMMUNOTHERAPY; N-FORMYLATED PEPTIDES;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL LOAD; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GLUTAMATE-AMMONIA LIGASE; IMMUNOLOGIC FACTORS; LUNG; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHILS; OLIGOPEPTIDES; REACTIVE OXYGEN SPECIES; SPLEEN; TUBERCULOSIS;

EID: 84891766266     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.09.010     Document Type: Article

References (26)

1. WHO report: Global tuberculosis control 258 2011
2. WHO Report of the expert consultation on immunother-apeutic interventions for tuberculosis 2007 Research and Training in Tropical Diseases (TDR) Geneva, Switzerland
3. J. Sheikh, G. Khuller, and I. Verma Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy J Immune Based Ther Vaccines 9 2011 4
4. C.L. Silva, V.L. Bonato, A.A. Coelho-Castelo, A.O. De Souza, S.A. Santos, and K.M. Lima et al. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice Gene Ther 12 2005 281 287
5. D.H. Yu, X.D. Hu, and H. Cai Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83 Gene Ther 15 2008 652 661
6. A. Mwinga, A. Nunn, B. Ngwira, C. Chintu, D. Warndorff, and P. Fine et al. Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial Lancet 360 2002 1050 1055
7. P. Barnes Immunotherapy for tuberculosis: wave of the future or tilting at windmills? Am J Respir Crit Care Med 168 2003 142 145
8. W. Fávaro, O. Nunes, F. Seiva, I.S. Nunes, L.K. Woolhiser, and N. Durán et al. Effects of P-MAPA Immunomodulator on Toll-Like receptors and p53: potential therapeutic strategies for infectious diseases and cancer Infect Agents Cancer 7 2012 14
9. M. Hedayat, K. Takeda, and N. Rezaei Prophylactic and therapeutic implications of toll-like receptor ligands Med Res Rev 32 2012 294 619
10. S. Karmakar, S. Bhaumik, J. Paul, and T. De TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis PLoS Pathog 8 2012
11. R. Medzhitov, and C. Janeway Jr. Innate immune recognition: mechanisms and pathways Immunol Rev 173 2000 89 97
12. M.A. Panaro, and V. Mitolo Cellular responses to FMLP challenging: a mini-review Immunopharmacol Immunotoxicol 21 1999 397 419
13. H. Fu, C. Dahlgren, and J. Bylund Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy Antimicrob Agents Chemother 47 2003 2545 2550
14. J.L. Gao, E.J. Lee, and P.M. Murphy Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor J Exp Med 189 1999 657 662
15. T. Doi, H. Yamada, T. Yajima, W. Wajjwalku, T. Hara, and Y. Yoshikai H2-M3-restricted CD8 + T cells induced by peptide-pulsed dendritic cells confer protection against Mycobacterium tuberculosis J Immunol 178 2007 3806 3813
16. G. Lauvau, and E.G. Pamer CD8 T cell detection of bacterial infection: sniffing for formyl peptides derived from Mycobacterium tuberculosis J Exp Med 193 2001 F35 F39
17. S. Khader, G. Bell, J. Pearl, J.J. Fountain, J. Rangel-Moreno, and G.E. Cilley et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4 + T cell responses after vaccination and during Mycobacterium tuberculosis challenge Nat Immunol 8 2007 369 446
18. X. Zhang, L. Majlessi, E. Deriaud, C. Leclerc, and R. Lo-Man Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils Immunity 31 2009 761 832
19. S.-Y. Eum, J.H. Kong, M.S. Hong, Y.J. Lee, J.H. Kim, and S.H. Hwang et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB Chest 137 2010 122 130
20. P. Redford, A. Boonstra, S. Read, J. Pitt, C. Graham, and E. Stavropoulos et al. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung Eur J Immunol 40 2010 2200 2210
21. D. Mader, M.J. Rabiet, F. Boulay, and A. Peschel Formyl peptide receptor-mediated proinflammatory consequences of peptide deformylase inhibition in Staphylococcus aureus Microbes Infect 12 2010 415 424
22. A. Sharma, S. Sharma, G. Khuller, and A. Kanwar In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv Int J Antimicrob Agents 34 2009 226 256
23. A. Sharma, G.K. Khuller, A.J. Kanwar, and S. Sharma Therapeutic potential of peptide deformylase inhibitors against experimental tuberculosis J Infect 60 2010 498 501
24. P. Murphy, H. Tiffany, D. McDermott, and S. Ahuja Sequence and organization of the human N-formyl peptide receptor-encoding gene Gene 133 1993 285 375
25. K. Veldkamp, H. Heezius, J. Verhoef, J.A. van Strijp, and K.P. van Kessel Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate Infect Immun 68 2000 5908 5921
26. M.B. Vanja, L.W. Nancy, R.U. James, L. Hall, G.D. Roberts, and F.R. Cockerill et al. Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid Antimicrob Agents Chemother 46 2002 2765 2771